Anti-MFSD2A/NLS1 antibody (ab217970)
Key features and details
- Rabbit polyclonal to MFSD2A/NLS1
- Suitable for: IHC-P
- Reacts with: Human
- Isotype: IgG
Overview
-
Product name
Anti-MFSD2A/NLS1 antibody
See all MFSD2A/NLS1 primary antibodies -
Description
Rabbit polyclonal to MFSD2A/NLS1 -
Host species
Rabbit -
Tested Applications & Species
See all applications and species dataApplication Species IHC-P Human
-
Immunogen
Synthetic peptide within Human MFSD2A/NLS1 aa 345-395 conjugated to keyhole limpet haemocyanin. The exact sequence is proprietary.
Database link: Q8NA29 -
Positive control
- Human placenta, Human larynx and Human liver carcinoma tissues.
-
General notes
This product was previously labelled as MFSD2A
Properties
-
Form
Liquid -
Storage instructions
Shipped at 4°C. Store at +4°C short term (1-2 weeks). Upon delivery aliquot. Store at -20°C long term. Avoid freeze / thaw cycle. -
Storage buffer
pH: 7.2
Preservative: 0.09% Sodium azide
Constituents: 1% BSA, 50% Glycerol (glycerin, glycerine)
Aqueous buffered solution -
Concentration information loading... -
Purity
Protein A purified -
Clonality
Polyclonal -
Isotype
IgG -
Research areas
Images
-
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-MFSD2A/NLS1 antibody (ab217970)
Immunohistochemical analysis of formalin-fixed and paraffin-embedded Human larynx tissue labeling MFSD2A/NLS1 with ab217970 at 1/200 dilution, followed by conjugation to the secondary antibody and DAB staining.
-
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-MFSD2A/NLS1 antibody (ab217970)Immunohistochemical analysis of formalin-fixed and paraffin-embedded Human placenta tissue labeling MFSD2A/NLS1 with ab217970 at 1/200 dilution, followed by conjugation to the secondary antibody and DAB staining.
-
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-MFSD2A/NLS1 antibody (ab217970)Immunohistochemical analysis of paraformaldehyde-fixed and paraffin-embedded Human liver carcinoma tissue labeling MFSD2A/NLS1 with ab217970 at 1/200 dilution, followed by conjugation to the secondary antibody and DAB staining.
